Therapeutic Potential of Growth Hormone in Peripheral Nerve Injury: Enhancing Schwann Cell Proliferation and Migration Through IGF ‐ 1R ‐ AKT and ERK Signaling Pathways
Glia · 2025-04 · 73 (4) · 805-821
DOI: 10.1002/glia.24653 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, online erschienen am 28.11.2024. Verfasst von Jiaqian Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Institute of Brain Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Schwann Cells, Cell Proliferation, Cell Movement, Peripheral Nerve Injuries. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: the Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University, GuangDong Basic and Applied Basic Research Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Peripheral nerve injury (PNI) represents a prevalent condition characterized by the demyelination of affected nerves. The challenge of remyelinating these nerves and achieving satisfactory functional recovery has long been a persistent issue. The specific contributions of growth hormone (GH) in the aftermath of PNI have remained ambiguous. Our investigations have demonstrated that GH not only enhances neurological function scores but also promotes remyelination within a three‐week period. Further in vivo studies corroborated that GH facilitates nerve function improvement by mitigating neuronal apoptosis. In vitro, the ideal concentration of GH for exerting effects on Schwann cells (SCs) has been identified as 80 ng/mL. Subsequent research uncovered GH's profound impact on SCs proliferation, cell cycle progression, and migration. Through RNA sequencing and additional experiments, it was discovered that GH treatment elevates the phosphorylation levels of IGF‐1R, AKT, and ERK. Moreover, the GH‐induced proliferation and migration of SCs were significantly diminished by the inhibition of the IGF‐1R pathway, achieved through pre‐treatment with Linsitinib. The outcomes of this investigation suggest that GH can significantly enhance the proliferation and migration of SCs, presenting it as a viable option for PNI repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Institute of Brain Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- College of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
ORCID-Profile: Jiaqian Chen
Förderung
- the Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University
- GuangDong Basic and Applied Basic Research Foundation
- National Natural Science Foundation of China
- Guangdong Medical Science and Technology Research Fund Project
- the President Foundation of Nanfang Hospital, Southern Medical University
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Chen, J., Zhang, T., Wang, C., Niu, P., Huang, L., Guo, R., Wu, C., Zhang, H., Wu, Z., Qi, S., & Liu, Y. (2025). Therapeutic Potential of Growth Hormone in Peripheral Nerve Injury: Enhancing Schwann Cell Proliferation and Migration Through IGF ‐ 1R ‐ AKT and ERK Signaling Pathways. Glia, 73(4), 805-821. https://doi.org/10.1002/glia.24653
Vancouver
Chen J, Zhang T, Wang C, Niu P, Huang L, Guo R, et al. Therapeutic Potential of Growth Hormone in Peripheral Nerve Injury: Enhancing Schwann Cell Proliferation and Migration Through IGF ‐ 1R ‐ AKT and ERK Signaling Pathways. Glia. 2025;73(4):805-821. doi:10.1002/glia.24653
BibTeX
@article{Chen2025,
author = {Chen, Jiaqian and Zhang, Tingcheng and Wang, Chaohu and Niu, Peirong and Huang, Liehao and Guo, Rongrong and Wu, Chengdong and Zhang, Huarong and Wu, Zhiyong and Qi, Songtao and Liu, Yi},
title = {Therapeutic Potential of Growth Hormone in Peripheral Nerve Injury: Enhancing Schwann Cell Proliferation and Migration Through IGF ‐ 1R ‐ AKT and ERK Signaling Pathways},
journal = {Glia},
year = {2025},
volume = {73},
number = {4},
pages = {805--821},
doi = {10.1002/glia.24653}
}
EUVIMED